Evolution of the Gynecologic Oncology Group protocols in the treatment of epithelial ovarian cancer
- PMID: 22343234
- DOI: 10.1097/GRF.0b013e318248050d
Evolution of the Gynecologic Oncology Group protocols in the treatment of epithelial ovarian cancer
Abstract
This chapter reviews some of the sentinel Gynecologic Oncology Group (GOG) ovarian trials, describes their rationale, provides summary tables for reference, and is organized into early ovarian cancer (GOG 1, 7601, 7602, 95, 157, 175, 212), advanced ovarian cancer optimal (2, 25, 52, 104, 114, 158, 172, 182, 178, 212, 252), and suboptimal disease (3, 22, 47, 97, 111, 162, 182, 218, 252, 262).
Similar articles
-
Chemotherapy for ovarian cancer: an evidence-based approach.Minerva Ginecol. 2004 Dec;56(6):539-45. Minerva Ginecol. 2004. PMID: 15729206 Review.
-
Gynecologic oncology group trials in ovarian carcinoma.Semin Oncol. 1997 Feb;24(1 Suppl 2):S2-10-S2-12. Semin Oncol. 1997. PMID: 9045325
-
Advances in the management of epithelial ovarian cancer.J Reprod Med. 2005 Jun;50(6):426-38. J Reprod Med. 2005. PMID: 16050567 Review.
-
Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-57-S15-61. Semin Oncol. 1997. PMID: 9346224 Clinical Trial.
-
Current status of chemotherapy for ovarian cancer.Semin Oncol. 1995 Oct;22(5 Suppl 12):61-6. Semin Oncol. 1995. PMID: 7481863 Review.
Cited by
-
Antitumor effects and mechanisms of dendritic cells stimulated by sCD40L on ovarian cancer cells in vitro.Onco Targets Ther. 2013 May 6;6:503-15. doi: 10.2147/OTT.S40504. Print 2013. Onco Targets Ther. 2013. PMID: 23671392 Free PMC article.
-
Refractory fallopian tube carcinoma - current perspectives in pathogenesis and management.Int J Womens Health. 2014 Jan 28;6:149-57. doi: 10.2147/IJWH.S40889. eCollection 2014. Int J Womens Health. 2014. PMID: 24511245 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical